Bayern Kapital

Bayern Kapital GmbH, established in 1995 and located in Landshut, Germany, serves as the venture capital arm of LfA Förderbank Bayern. The firm specializes in providing growth capital to small and medium-sized enterprises exclusively within Bavaria, focusing on high-tech sectors such as biotechnology, life sciences, information technology, medical technology, new materials, nanotechnology, and environmental technology. Bayern Kapital aims to support the financing of research and development, market launches of new products, and expansion of existing market shares. The company typically invests between €0.25 million and €9 million in firms with annual sales up to €50 million or total assets not exceeding €43 million. Bayern Kapital has invested in over 250 companies, managing funds valued at approximately €340 million.

Stefan Aumer

Investment Analyst

Matthias Birnthaler

Investment Analyst

Matthias Buchinger

Investment Manager

Riccardo Giacomello

Investment Analyst

Ariel Golan

Senior Investment Manager

Regina Graßl

Senior Investment Manager

Roman Huber

Managing Director

Wolfgang Härtl

Investment Director

Anja Krzystek

Investment Analyst

Bernhard Köhler

Investment Director and Authorized Signatory

Johanna Liebner

Senior Investment Manager

Brigitte Linseis

Senior Investment Manager

Thomas Manitta

Senior Investment Manager

Mathias Matusek

Investment Manager

Franziska Pfeiffer

Investment Manager

Markus Porsch

Investment Analyst

Martin Redl

Investment Director

Dr. Georg Ried

Managing Director

Franz Salzer

Senior Investment Manager

Bernd Schafberger

Investment Director

Benjamin Schwiewagner

Investment Director

Florian Zeidle

Investment Analyst

Matthias Buchinger

Investment Manager

Past deals in Wearables

Vantis

Series A in 2025
Vantis is a provider of holistic primary healthcare services focused on the management of chronic diseases. The company offers a hybrid care model that combines digital health solutions with a network of healthcare facilities to enhance health outcomes and improve access to care. Its Vantis Heart App plays a crucial role in this model by assisting users in accurately measuring blood pressure, managing medication, and adopting heart-healthy nutrition and exercise routines. By following European guidelines for heart disease treatment, the app empowers individuals to take charge of their health at home, promoting relaxation and overall well-being.

SmartAIs

Pre Seed Round in 2025
SmartAI develops an innovative digital assistant designed to assist blind and visually impaired individuals with outdoor navigation. The system employs cameras and sensors to identify obstacles, such as pedestrians, vehicles, and curbs, providing real-time auditory feedback through headphones. Users receive directional instructions and warnings about potential hazards, enhancing their safety while navigating. The assistant also incorporates GPS technology to determine the most efficient routes, adapting to obstacles or changes in the environment. Interaction with the system is facilitated through voice commands, allowing for continuous updates on surroundings and navigation paths. Additionally, SmartAI's technology learns user preferences, creating a more personalized navigation experience. The integration of bone-conduction headphones further enhances user safety by allowing users to hear ambient sounds while receiving guidance.

German Bionic

Series A in 2023
German Bionic is a manufacturer of innovative exoskeletons designed to enhance efficiency and productivity in industrial settings. The company has developed the Cray X, the world's first connected exoskeleton, which integrates with Smart Factory systems to self-learn and reinforce proper lifting techniques, thereby preventing incorrect posture. This technology serves as an intelligent interface between humans and machines, providing valuable data that demonstrates its effectiveness in protecting workers' health and significantly reducing the risk of accidents and strain-related injuries. Supported by prominent investors such as Samsung Catalyst Fund and Storm Ventures, German Bionic has received numerous accolades, including the German Entrepreneur Award and the Automatica Award, highlighting its impact on improving workplace safety and operational processes.

InContAlert

Pre Seed Round in 2023
InContAlert is a deep tech start-up focused on improving the lives of individuals with bladder dysfunction through innovative medical technology. The company has developed an mHealth device that allows users to monitor the filling level of their urinary bladder without the need for catheters or frequent intervention from healthcare professionals. The device, which can be fastened using a belly band or clipped to underwear, features a sensor positioned just above the pubic bone to continuously measure bladder levels. This data is transmitted to an accompanying app, which alerts users when a predefined filling level is reached, thereby reducing the risk of uncontrolled urine loss and preventing harmful bladder distension. By leveraging deep learning algorithms for data analysis, InContAlert empowers incontinence patients to regain control and enjoy a more carefree lifestyle.

German Bionic

Series A in 2022
German Bionic is a manufacturer of innovative exoskeletons designed to enhance efficiency and productivity in industrial settings. The company has developed the Cray X, the world's first connected exoskeleton, which integrates with Smart Factory systems to self-learn and reinforce proper lifting techniques, thereby preventing incorrect posture. This technology serves as an intelligent interface between humans and machines, providing valuable data that demonstrates its effectiveness in protecting workers' health and significantly reducing the risk of accidents and strain-related injuries. Supported by prominent investors such as Samsung Catalyst Fund and Storm Ventures, German Bionic has received numerous accolades, including the German Entrepreneur Award and the Automatica Award, highlighting its impact on improving workplace safety and operational processes.

ProGlove

Series A in 2018
ProGlove is a company that specializes in designing and manufacturing innovative industrial wearables, specifically wireless gloves equipped with barcode scanning and gesture-sensing technology. Founded in 2014, ProGlove's products are aimed at enhancing efficiency and productivity for workers in logistics and manufacturing. These smart gloves allow employees to perform tasks hands-free, enabling them to scan items while simultaneously engaging in other activities. By facilitating multi-tasking and providing instant feedback, ProGlove's solutions contribute to improved ergonomics and streamlined workflows, ultimately helping organizations automate repetitive processes and enhance overall operational performance.

ProGlove

Seed Round in 2016
ProGlove is a company that specializes in designing and manufacturing innovative industrial wearables, specifically wireless gloves equipped with barcode scanning and gesture-sensing technology. Founded in 2014, ProGlove's products are aimed at enhancing efficiency and productivity for workers in logistics and manufacturing. These smart gloves allow employees to perform tasks hands-free, enabling them to scan items while simultaneously engaging in other activities. By facilitating multi-tasking and providing instant feedback, ProGlove's solutions contribute to improved ergonomics and streamlined workflows, ultimately helping organizations automate repetitive processes and enhance overall operational performance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.